These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16890825)

  • 1. ESPRIT trial.
    Flaherty ML; Kissela B; Broderick JP
    Lancet; 2006 Aug; 368(9534):448; author reply 449. PubMed ID: 16890825
    [No Abstract]   [Full Text] [Related]  

  • 2. ESPRIT trial.
    O'Donnell M; Eikelboom JW
    Lancet; 2006 Aug; 368(9534):447; author reply 449. PubMed ID: 16890824
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet; 2006 May; 367(9523):1665-73. PubMed ID: 16714187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole with aspirin for secondary stroke prevention.
    Norrving B
    Lancet; 2006 May; 367(9523):1638-9. PubMed ID: 16714170
    [No Abstract]   [Full Text] [Related]  

  • 5. ESPRIT trial.
    von Maxen A; Wille H; Schoenhoefer PS
    Lancet; 2006 Aug; 368(9534):448-9; author reply 449. PubMed ID: 16890826
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin, chance, and results in relation to blood pressure.
    López-Rodríguez I; Rodríguez-Ledo MP
    Hypertension; 2004 Apr; 43(4):e22-3; author reply e22-3. PubMed ID: 14967832
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS; Skalabrin EJ; Kraiss LW
    Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESPRIT study design and outcomes--a critical appraisal.
    Einhäupl K
    Curr Med Res Opin; 2007 Feb; 23(2):271-3. PubMed ID: 17288680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESPRIT trial.
    Filippi A
    Lancet; 2006 Aug; 368(9534):447-8; author reply 449. PubMed ID: 16890823
    [No Abstract]   [Full Text] [Related]  

  • 10. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
    Rouhl RP; Lodder J
    Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone.
    Delanty N
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):832. PubMed ID: 10617388
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone.
    Jolobe OM
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):832. PubMed ID: 10617389
    [No Abstract]   [Full Text] [Related]  

  • 13. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].
    Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Touboul D; Touboul PJ
    Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?
    Halkes PH; Algra A
    Cerebrovasc Dis; 2007; 24 Suppl 1():107-11. PubMed ID: 17971645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
    Lutsep HL
    J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapies in cerebrovascular disease: what should we use as secondary prevention in patients with carotid artery disease?
    Beckman JA
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S12-6. PubMed ID: 19530155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipyretic therapy in acute stroke.
    Büttner Th; Müller Th; Hellwig K; Meves S; Kuhn W
    Lancet; 1998 Aug; 352(9129):740. PubMed ID: 9729020
    [No Abstract]   [Full Text] [Related]  

  • 18. Comments in response to "low-dose aspirin increases aspirin resistance in patients with coronary artery disease".
    Fisher M; Knappertz V
    Am J Med; 2006 Mar; 119(3):287; author reply 287-8. PubMed ID: 16490484
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyridamole plus aspirin: the best regimen for stroke prevention after noncardioembolic focal cerebral ischemia.
    Jonas S; Grieco G
    Cerebrovasc Dis; 2006; 22(1):1-3. PubMed ID: 16567930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.